Psychopharmacology for the Clinician
Open Access
To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians
Anna Muntingh, Neeltje Batelaan, Willemijn Scholten and Anton J. van Balkom
J Psychiatry Neurosci May 01, 2021 46 (3) E388-E389; DOI: https://doi.org/10.1503/jpn.200099
Anna Muntingh
From the Amsterdam UMC, VU University, Psychiatry, Amsterdam Public Health research institute, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom); and the GGZ inGeest Specialized Mental Health Care, Amsterdam, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom)
PhDNeeltje Batelaan
From the Amsterdam UMC, VU University, Psychiatry, Amsterdam Public Health research institute, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom); and the GGZ inGeest Specialized Mental Health Care, Amsterdam, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom)
MD, PhDWillemijn Scholten
From the Amsterdam UMC, VU University, Psychiatry, Amsterdam Public Health research institute, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom); and the GGZ inGeest Specialized Mental Health Care, Amsterdam, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom)
PhDAnton J. van Balkom
From the Amsterdam UMC, VU University, Psychiatry, Amsterdam Public Health research institute, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom); and the GGZ inGeest Specialized Mental Health Care, Amsterdam, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom)
MD, PhDIn this issue
Article tools
To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians
Anna Muntingh, Neeltje Batelaan, Willemijn Scholten, Anton J. van Balkom
J Psychiatry Neurosci May 2021, 46 (3) E388-E389; DOI: 10.1503/jpn.200099
Related Articles
- No related articles found.
Cited By...
- No citing articles found.